Bleeding Complications After Percutaneous Native Kidney Biopsy: Results From the Boston Kidney Biopsy Cohort
- PMID: 32274455
- PMCID: PMC7136322
- DOI: 10.1016/j.ekir.2020.01.012
Bleeding Complications After Percutaneous Native Kidney Biopsy: Results From the Boston Kidney Biopsy Cohort
Abstract
Background: The major risk of kidney biopsy is severe bleeding. Numerous risk factors for bleeding after biopsy have been reported, but findings have been inconsistent.
Methods: We retrospectively reviewed medical records of adult patients enrolled in a native kidney biopsy cohort study to identify major bleeding events (red blood cell [RBC] transfusions, invasive procedures, kidney loss, or death). We used logistic and linear regression models to identify characteristics associated with postbiopsy RBC transfusions and decline in hemoglobin within a week after the procedure.
Results: Major bleeding events occurred in 28 of 644 (4.3%) patients (28 required an RBC transfusion, 4 underwent angiographic intervention, and 1 had open surgery to control bleeding). No patient lost a kidney or died because of the biopsy. Postbiopsy RBC transfusion risk was driven by the baseline hemoglobin level (odds ratio [OR] 13.6; 95% confidence interval [CI] 5.4-34.1 for hemoglobin <10 vs. ≥10 g/dl). After adjusting for hemoglobin, no other patient characteristics were independently associated with RBC transfusions. Female sex (β = 0.18; 95% CI: 0.04-0.32), estimated glomerular filtration rate (eGFR) <30 ml/min per 1.73 m2 (β = 0.32; 95% CI: 0.14-0.49), and baseline hemoglobin (β = 0.09; 95% CI: 0.05-0.13, per g/dl increase) were independently associated with a larger drop in hemoglobin. Histopathologic lesions were not independently associated with major bleeding after biopsy.
Conclusion: Biopsies were generally well tolerated. Baseline hemoglobin was the dominant risk factor for RBC transfusions, but female sex and eGFR <30 ml/min per 1.73 m2 were also associated with a larger decline in hemoglobin after the procedure.
Keywords: biopsy; bleeding; blood transfusions; kidney diseases; risk factors.
© 2020 International Society of Nephrology. Published by Elsevier Inc.
Figures
References
-
- Luciano R.L., Moeckel G.W. Update on the native kidney biopsy: core curriculum 2019. Am J Kidney Dis. 2019;73:404–415. - PubMed
-
- Richards N.T., Darby S., Howie A.J. Knowledge of renal histology alters patient management in over 40% of cases. Nephrol Dial Transplant. 1994;9:1255–1259. - PubMed
-
- Botti R.E., Razzak M.A., MacIntyre W.J., Pritchard W.H. The relationship of renal blood flow to cardiac output in normal individuals as determined by concomitant radioisotopic measurements. Cardiovasc Res. 1968;2:243–246. - PubMed
-
- Doyle A.J., Gregory M.C., Terreros D.A. Percutaneous native renal biopsy: comparison of a 1.2-mm spring-driven system with a traditional 2-mm hand-driven system. Am J Kidney Dis. 1994;23:498–503. - PubMed
-
- Riehl J., Maigatter S., Kierdorf H. Percutaneous renal biopsy: comparison of manual and automated puncture techniques with native and transplanted kidneys. Nephrol Dial Transplant. 1994;9:1568–1574. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous
